Intervention

Tarceva (erlotinib HCl)

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00091663 · 2004-08-01

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)NCT00095225 · 2004-07-01

A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung CancerNCT00047736 · 2001-07-01

Common conditions

Lung Cancer2 Non-small-cell Lung Carcinoma2 Neoplasm Recurrence, Local1

Leading sponsors

Genentech, Inc.3

Trial status mix

COMPLETED3

Phase mix

PHASE32

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.